Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Belton Syrup is a combination nutritional supplement developed and marketed by Taqwa Pharmaceuticals. The formulation consists of a comprehensive blend of essential B-complex vitamins—including thiamine (B1), riboflavin (B2), nicotinamide (B3), panthenol (B5), pyridoxine (B6), and cyanocobalamin (B12)—supplemented with the essential amino acid L-lysine. It is primarily indicated for the prevention and treatment of vitamin B deficiencies and is frequently utilized as an appetite stimulant and nutritional support to promote healthy growth and development, particularly in pediatric populations. The B-vitamins serve as critical coenzymes in various metabolic processes, including energy production and neurological function, while lysine supports protein synthesis and calcium absorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thiamine + riboflavin + nicotinamide + panthenol + pyridoxine + cyanocobalamin + lysine.